Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2026-02-25 @ 6:31 PM
Study NCT ID:
NCT06609850
Status:
RECRUITING
Last Update Posted:
2024-12-03
First Post:
2024-09-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma
Sponsor:
Organization: